Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epididymal-specific lipocalin-6 (LCN6) is a member of the lipocalin protein family, characterized by a conserved eight-stranded antiparallel β-barrel structure capable of binding and transporting hydrophobic molecules[1][4][6][5]. LCN6 is highly specific to the human epididymis at the transcript level and is localized on spermatozoa, suggesting a specialized function in human reproduction, potentially related to sperm maturation or interaction[1][5]. The protein is distinct in its sequence but retains the classic lipocalin fold, indicating evolutionary conservation within this gene family[1]. Unlike other closely related lipocalins, LCN6 lacks a c-terminal cysteine, possibly allowing for a broader ligand range[1]. Functional and disease associations are currently limited; there is no direct evidence for roles in major diseases or as a therapeutic target[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epididymal-specific lipocalin-6 (LCN6).